These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30663980)

  • 1. Population pharmacokinetics and dosage optimization of tacrolimus in pediatric patients with nephrotic syndrome
.
    Wang X; Han Y; Chen C; Ma L; Xiao H; Zhou Y; Cui Y; Wang F; Su B; Yao Y; Ding J
    Int J Clin Pharmacol Ther; 2019 Mar; 57(3):125-134. PubMed ID: 30663980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus Population Pharmacokinetic Model in Adult Chinese Patients with Nephrotic Syndrome and Dosing Regimen Identification Using Monte Carlo Simulations.
    Liao M; Wang M; Zhu X; Zhao L; Zhao M
    Ther Drug Monit; 2022 Oct; 44(5):615-624. PubMed ID: 36101928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose tailoring of tacrolimus based on a non-linear pharmacokinetic model in children with refractory nephrotic syndrome.
    Li L; Zhu M; Li DY; Guo HL; Hu YH; Xu ZY; Jing X; Chen F; Zhao F; Li YM; Xu J; Jiao Z
    Int Immunopharmacol; 2021 Sep; 98():107827. PubMed ID: 34284341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
    Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
    Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosage Optimization Based on Population Pharmacokinetic Analysis of Tacrolimus in Chinese Patients with Nephrotic Syndrome.
    Lu T; Zhu X; Xu S; Zhao M; Huang X; Wang Z; Zhao L
    Pharm Res; 2019 Feb; 36(3):45. PubMed ID: 30719576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.
    Vadcharavivad S; Praisuwan S; Techawathanawanna N; Treyaprasert W; Avihingsanon Y
    J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Population pharmacokinetic study of tacrolimus in patients with hematopoietic stem cell transplant].
    Xue L; Rui JZ; Zhang Y; Miao LY
    Yao Xue Xue Bao; 2009 Oct; 44(10):1145-51. PubMed ID: 20055140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosage optimization of tacrolimus based on the glucocorticoid dose and pharmacogenetics in adult patients with systemic lupus erythematosus.
    Wang CB; Zhang YJ; Zhao MM; Zhao L
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110866. PubMed ID: 37678026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients.
    Sam WJ; Aw M; Quak SH; Lim SM; Charles BG; Chan SY; Ho PC
    Br J Clin Pharmacol; 2000 Dec; 50(6):531-41. PubMed ID: 11136292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of tacrolimus in children with nephrotic syndrome.
    Hao GX; Huang X; Zhang DF; Zheng Y; Shi HY; Li Y; Jacqz-Aigrain E; Zhao W
    Br J Clin Pharmacol; 2018 Aug; 84(8):1748-1756. PubMed ID: 29637588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic study of tacrolimus in pediatric patients with primary nephrotic syndrome: A comparison of linear and nonlinear Michaelis-Menten pharmacokinetic model.
    Huang L; Liu Y; Jiao Z; Wang J; Fang L; Mao J
    Eur J Pharm Sci; 2020 Feb; 143():105199. PubMed ID: 31862313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients.
    Zhang XQ; Wang ZW; Fan JW; Li YP; Jiao Z; Gao JW; Peng ZH; Liu GL
    Ther Drug Monit; 2012 Apr; 34(2):126-33. PubMed ID: 22377746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic analysis of tacrolimus in Chinese cardiac transplant recipients.
    Gong Y; Yang M; Sun Y; Li J; Lu Y; Li X
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e12-e18. PubMed ID: 32296499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Population pharmacokinetics of tacrolimus in Chinese renal transplant patients].
    Zhang GM; Li L; Chen WQ; Bi SS; Liu X; Zhang XL; Lu W
    Yao Xue Xue Bao; 2008 Jul; 43(7):695-701. PubMed ID: 18819472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial Dosage Optimization of Tacrolimus in Pediatric Patients With Thalassemia Major Undergoing Hematopoietic Stem Cell Transplantation Based on Population Pharmacokinetics.
    Zhou S; Zhang R; Lv C; Lu J; Wei Y; Li C; Chen M; Li Q; Liu T
    Ann Pharmacother; 2021 Apr; 55(4):440-451. PubMed ID: 32924532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantation.
    Yang JW; Liao SS; Zhu LQ; Zhao Y; Zhang Y; Sun XY; Rao W; Qu W; Li WZ; Sun LY
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):75-83. PubMed ID: 25207550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation.
    Staatz CE; Willis C; Taylor PJ; Lynch SV; Tett SE
    Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipients.
    Lee JY; Hahn HJ; Son IJ; Suh KS; Yi NJ; Oh JM; Shin WG
    Pharmacotherapy; 2006 Aug; 26(8):1069-77. PubMed ID: 16863483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
    Staatz CE; Tett SE
    Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of tacrolimus in pediatric refractory nephrotic syndrome and a summary of other pediatric disease models.
    Wang D; Lu J; Li Q; Li Z
    Exp Ther Med; 2019 May; 17(5):4023-4031. PubMed ID: 31007740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.